Search - tctmd.com

Displaying 141 - 160 of 210

Sort: Relevancy | Date

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Industry News

Svelte Medical Systems Announces European Launch of SLENDER IDS™

January 18, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

Advertisement

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

TCTMD’s Top 10 Most Popular Stories for January 2016

Svelte Medical Systems Announces European Launch of SLENDER IDS™

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Debaters Question Need for Further Stent Innovation

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Absorb BVS Matches Xience V in Chinese Patients

Novel Devices Present New Treatment Options for STEMI

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content